• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在欧盟临床试验注册处登记的印度试验地点记录中的三个差异级别。

Three levels of discrepancies in the records of trial sites in India, registered with the European Union Clinical Trials Register.

作者信息

Samanta Anwesha Dhal, Borah Rishima, Saberwal Gayatri

机构信息

Institute of Bioinformatics and Applied Biotechnology, Bengaluru, India.

出版信息

Front Med (Lausanne). 2024 Jul 5;11:1357930. doi: 10.3389/fmed.2024.1357930. eCollection 2024.

DOI:10.3389/fmed.2024.1357930
PMID:39036096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11257842/
Abstract

INTRODUCTION

Clinical trial registries serve a key role in tracking the trial enterprise. We are interested in the record of trials sites in India. In this study, we focused on the European Union Clinical Trial Registry (EUCTR). This registry is complex because a given study may have records from multiple countries in the EU, and therefore a given study ID may be represented by multiple records. We wished to determine what steps are required to identify the studies that list sites in India that are registered with EUCTR.

METHODS

We used two methodologies. Methodology A involved downloading the EUCTR database and querying it. Methodology B used the search function on the registry website.

RESULTS

Discrepant information, on whether or not a given study listed a site in India, was identified at three levels: (i) the methodology of examining the database; (ii) the multiple records of a given study ID; and (iii) the multiple fields within a given record. In each of these situations, there was no basis to resolve the discrepancy, one way or another.

DISCUSSION

This work contributes to methodologies for more accurate searches of trial registries. It also adds to the efforts of those seeking transparency in trial data.

摘要

引言

临床试验注册在跟踪试验事业方面发挥着关键作用。我们对印度试验地点的记录感兴趣。在本研究中,我们重点关注欧盟临床试验注册库(EUCTR)。该注册库很复杂,因为一项特定研究可能在欧盟多个国家都有记录,因此一个特定的研究编号可能由多条记录表示。我们希望确定需要采取哪些步骤来识别在EUCTR注册的、列出印度试验地点的研究。

方法

我们使用了两种方法。方法A包括下载EUCTR数据库并进行查询。方法B使用注册库网站上的搜索功能。

结果

在三个层面发现了关于一项特定研究是否列出印度试验地点的不一致信息:(i)检查数据库的方法;(ii)一个特定研究编号的多条记录;以及(iii)一条特定记录中的多个字段。在上述每种情况下,都没有办法以任何一种方式解决这种不一致。

讨论

这项工作有助于采用更准确的方法搜索试验注册库。它也为那些寻求试验数据透明度的人所做的努力增添了内容。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d6/11257842/897f143b9ca9/fmed-11-1357930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d6/11257842/74d688c3ba4c/fmed-11-1357930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d6/11257842/897f143b9ca9/fmed-11-1357930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d6/11257842/74d688c3ba4c/fmed-11-1357930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d6/11257842/897f143b9ca9/fmed-11-1357930-g002.jpg

相似文献

1
Three levels of discrepancies in the records of trial sites in India, registered with the European Union Clinical Trials Register.在欧盟临床试验注册处登记的印度试验地点记录中的三个差异级别。
Front Med (Lausanne). 2024 Jul 5;11:1357930. doi: 10.3389/fmed.2024.1357930. eCollection 2024.
2
Identifying trials run in India that are registered in other clinical trial registries: a cross-sectional study.识别在其他临床试验注册机构注册的在印度开展的试验:一项横断面研究。
BMC Med Res Methodol. 2024 Sep 12;24(1):201. doi: 10.1186/s12874-024-02336-w.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study.欧盟临床试验注册库中注册的临床试验结果的可获取性:横断面审计研究
BMJ Med. 2024 Jan 12;3(1):e000738. doi: 10.1136/bmjmed-2023-000738. eCollection 2024.
5
Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register.临床试验状态差异的流行率:一项在 ClinicalTrials.gov 和欧盟临床试验注册中心登记的 10492 项试验的横断面研究。
PLoS One. 2018 Mar 7;13(3):e0193088. doi: 10.1371/journal.pone.0193088. eCollection 2018.
6
Trends and variation in data quality and availability on the European Union Clinical Trials Register: A cross-sectional study.欧盟临床试验注册中心数据质量和可获得性的趋势和变化:一项横断面研究。
Clin Trials. 2022 Apr;19(2):172-183. doi: 10.1177/17407745211073483. Epub 2022 Feb 11.
7
Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match.来自印度药品监管机构以及“印度临床试验注册中心”的数据并非总是一致。
Front Med (Lausanne). 2024 Feb 15;11:1346208. doi: 10.3389/fmed.2024.1346208. eCollection 2024.
8
Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis.未注册、中止和不发表随机试验:一项重复的荟萃分析研究。
PLoS Med. 2022 Apr 27;19(4):e1003980. doi: 10.1371/journal.pmed.1003980. eCollection 2022 Apr.
9
Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law.潜在重复:数以百计的印度临床试验已在 ClinicalTrials.gov 注册,但根据法律要求,这些试验并未在印度注册。
PLoS One. 2020 Jun 19;15(6):e0234925. doi: 10.1371/journal.pone.0234925. eCollection 2020.
10
Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.遵守在欧盟临床试验注册库中报告结果的要求:队列研究与网络资源
BMJ. 2018 Sep 12;362:k3218. doi: 10.1136/bmj.k3218.

本文引用的文献

1
Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match.来自印度药品监管机构以及“印度临床试验注册中心”的数据并非总是一致。
Front Med (Lausanne). 2024 Feb 15;11:1346208. doi: 10.3389/fmed.2024.1346208. eCollection 2024.
2
In Clinical Trials Registry-India, the classification of sponsors needs to be standardised.在临床试验注册印度,需要对赞助商的分类进行标准化。
Indian J Med Ethics. 2024 Jan-Mar;IX(1):11-18. doi: 10.20529/IJME.2023.071.
3
An analysis of deficiencies in the ethics committee data of certain interventional trials registered with the Clinical Trials Registry-India.
对在印度临床试验注册中心注册的某些干预性试验伦理委员会数据缺陷的分析。
PLOS Glob Public Health. 2022 Oct 24;2(10):e0000617. doi: 10.1371/journal.pgph.0000617. eCollection 2022.
4
Impact of searching clinical trials registers in systematic reviews of pharmaceutical and non-pharmaceutical interventions: Reanalysis of meta-analyses.药物和非药物干预措施系统评价中检索临床试验注册库的影响:荟萃分析再分析。
Res Synth Methods. 2023 Jan;14(1):52-67. doi: 10.1002/jrsm.1583. Epub 2022 Jul 28.
5
Searching clinical trials registers: guide for systematic reviewers.检索临床试验注册库:系统评价者指南
BMJ. 2022 Apr 26;377:e068791. doi: 10.1136/bmj-2021-068791.
6
Reliability of Trial Information Across Registries for Trials With Multiple Registrations: A Systematic Review.多注册试验的注册库间试验信息的可靠性:系统评价。
JAMA Netw Open. 2021 Nov 1;4(11):e2128898. doi: 10.1001/jamanetworkopen.2021.28898.
7
A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one.重要公共临床试验注册库的比较分析,及一个临时理想库的建议。
PLoS One. 2021 May 11;16(5):e0251191. doi: 10.1371/journal.pone.0251191. eCollection 2021.
8
Using the Cochrane Central Register of Controlled Trials to identify clinical trial registration is insufficient: a cross-sectional study.使用 Cochrane 中央对照试验注册中心来识别临床试验注册是不够的:一项横断面研究。
BMC Med Res Methodol. 2020 Jul 25;20(1):200. doi: 10.1186/s12874-020-01083-y.
9
Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law.潜在重复:数以百计的印度临床试验已在 ClinicalTrials.gov 注册,但根据法律要求,这些试验并未在印度注册。
PLoS One. 2020 Jun 19;15(6):e0234925. doi: 10.1371/journal.pone.0234925. eCollection 2020.
10
An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India.对临床试验注册中心 - 印度登记的介入性药物试验数据缺陷的分析。
Trials. 2019 Aug 28;20(1):535. doi: 10.1186/s13063-019-3592-0.